XERS - Xeris Biopharma Holdings, Inc. Company Long-Term Liabilities

This daily price chart for Xeris Biopharma (XERS) demonstrates the impact of market adoption of new injectables and insurance reimbursements, with the indicator standing at 0.00. The business relies on the demand for ready-to-use solutions, which are rapidly capturing their niche due to ease of administration. Revenue stability is driven by unique formulas that protect the portfolio from competitors and generate positive free cash flow.

This metric aggregates the total volume of credit obligations with maturities exceeding twelve months, reflecting the long-term debt load on capital. By analyzing the company's long-term debt trend, an investor assesses the stability of the financing structure, which is critical for Xeris Biopharma (XERS) when scaling injectable drug sales and reaching the break-even point to stabilize its financial position.